
(Incorporated in
(Registration Number: 12886458)
LEI :213800HFVHGJ9YGO9F71
Share code on the LSE: MAST
ISIN: GB00BNG90H86
Dated: 9 February 2026
("Quantum", "QDE" or the "Company")
Business Growth Update and Acceleration Capital Funding
As a result of the progress made and to fund QDE's capital requirements for the abovementioned project capex, an acceleration capital funding (the "
Pieter Krügel, CEO at Quantum Data Energy PLC, said: "We are excited about the ongoing progress that we are making as we continue to build our portfolio of flexgen assets to our initial target of 300 MW and beyond. The Acceleration Capital has been undertaken solely to support the expeditious completion of an immediate growth opportunity that will make a meaningful contribution to QDE's portfolio of MWs in production. We are also working on a number of additional near term growth opportunities and look forward to updating the market with further updates in due course."
Admission and Total Voting Rights:
Application will be made for the admission of the 46,600,000 Placing Shares to trading on the LSE ("Admission") pursuant to the authorities approved by shareholders at the General Meeting on
Following Admission, the Company's issued share capital will consist of 223,129,152 ordinary shares with voting rights. The Company does not hold any ordinary shares in treasury. This figure of 223,129,152 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they require to notify their interest in, or a change to their interest in, the share capital of the Company under the
Stay up to date with QDE's latest news and updates by joining our emailing list and social media channels, as follows:
|
Website |
|
|
General enquires |
|
|
RNS email alerts |
|
|
|
|
|
X (formerly Twitter) |
@mastplc |
About
ENDS
This announcement contains inside information for the purposes of the
|
Pieter Krügel |
|
CEO |
|
|
|
+44 (0)203 4117773 |
|
Corporate Broker |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the